Short-and intermediate-term efficacy of amiodarone in infants and children with cardiac arrhythmia

Turkish Journal of Pediatrics

Volumn 39, Issue 2, 1997, Pages 219-225

  Çeliker, Alpay ^a   Koçak, Gülendam ^a   Koray Lenk, M ^a   Alehan, Dursun ^a   Özme, Şencan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Amiodarone; Arrhythmia; Childhood

Indexed keywords

AMIODARONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART VENTRICLE ARRHYTHMIA; HUMAN; INFANT; KERATOPATHY; LIVER TOXICITY; MALE; ORAL DRUG ADMINISTRATION; SUPRAVENTRICULAR TACHYCARDIA; THYROID DISEASE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGE FACTORS; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CHILD; CHILD, PRESCHOOL; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0030805689     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Nalos PC, Ismail Y, Pappas JM, Nyitray W, DonMichael TA. Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation. Am Heart J 1991; 122: 1629-1632.
2. Kannan R, Yabek SM, Garson A Jr, Miller S, McVey P, Singh BN. Amiodarone efficacy in a young population: relationship to serum amiodarone and desethylamiodarone levels. Am Heart J 1987; 114: 283-287.
3. Touboul P, Atallah G, Gressard A, Kirkorian G. Effects of amiodarone on sinus node in man. Br Heart J 1979; 42: 573-578.
4. Cournel P, Fidelle J. Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases. Am Heart J 1980; 100: 1063-1069.
5. Pongiglione G, Strasburger JF, Deal BJ, Benson DW Jr. Use of amiodarone for short-term and adjuvant therapy in young patients. Am J Cardiol 1991; 68: 603-608.
6. Koren G, Hesslein PS, MacLeod SM. Digoxin toxicity associated with amiodarone therapy in children. J Pediatr 1984; 104: 467-470.
7. Shahar E, Barzilay Z, Frand M, Feigl A. Amiodarone in control of sustained tachyarrhythmias in children with Wolf-Parkinson-White syndrome. Pediatrics 1983; 72: 813-816.
8. Guccione P, Paul T, Garson Ajr. Long-term follow-up of amiodarone therapy in the young: continued-efficacy, unimpaired growth, moderate side effects. J Am Coll Cardiol 1990, 15: 1118-1124.
9. Shahar E, Barzilay Z, Shem-Tov AA, Shohet I, Frand M. Pre-excitation syndrome in infants and children. Effect of digoxin, verapamil, and amiodarone. Arch Dis Child 1983; 58: 207-211.
10. Costigan DC, Holland FJ, Daneman D, Hesslein PS, Vogel M, Ellis G. Amiodarone therapy, effects on childhood thyroid function. Pediatrics 1986; 77: 703-708.
11. Martin WJ 2d, Rosenow EC 3rd. Amiodarone pulmonary toxicity. Recognition and pathogenesis. Chest 1988; 93: 1067-1075.
12. Hohnloser SH, Meinertz T, Dammbacher T, et al. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. Am Heart J 1991; 121: 89-95.
13. Figa FH, Gow RM, Hamilton RM, Freedom RM. Clinical efficacy and safety of intravenous amiodarone in infants and children. Am J Cardiol 1994; 74: 573-577.
14. Jung W, Mletzko R, Manz M, Nitsch J, Lüderitz B. Efficacy and safety of combination therapy with amiodarone and type I agents for treatment of inducible ventricular tachycardia. PACE 1993; 16: 778-788.
15. Çeliker A, Brugada P. Radiofrequency catheter ablation of accessory pathways and modification of atrioventricular node in children and adolescents. Turk J Pediatr 1996; 38: 467-475.
16. st ed). Philadelphia: Hanley and Belfus; 1992: 377-434.